Sg Americas Securities, LLC Jounce Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$0.9 - $1.85 $1,404 - $2,886	1,560 Added 11.44%	15,195 $28,000
Q4 2022 Feb 02, 2023	BUY	$0.64 - $1.99 $89 - $278	140 Added 1.04%	13,635 $15,000
Q3 2022 Oct 31, 2022	SELL	$2.73 - $4.92 $6,205 - $11,183	-2,273 Reduced 14.42%	13,495 $32,000
Q2 2022 Jul 29, 2022	BUY	$2.8 - $7.67 $44,150 - $120,940	15,768 New	15,768 $48,000
Q4 2021 Feb 07, 2022	SELL	$7.11 - $9.64 $166,324 - $225,508	-23,393 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$5.04 - $8.73 $117,900 - $204,220	23,393 New	23,393 $174,000
Q1 2019 Apr 29, 2019	SELL	$3.43 - $6.87 $55,610 - $111,383	-16,213 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$2.69 - $6.71 $43,612 - $108,789	16,213 New	16,213 $55,000
Q1 2018 May 03, 2018	SELL	$13.4 - $28.4 $309,258 - $655,443	-23,079 Closed	0 $0
Q4 2017 Jan 24, 2018	BUY	$12.52 - $17.82 $288,949 - $411,267	23,079	23,079 $294,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.